| David Chiapaikeo, MD | |
|
2109 Doctors Park Dr, Columbus, IN 47203-2224 | |
| (812) 372-2245 | |
| (812) 375-2156 |
| Full Name | David Chiapaikeo |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 13 Years |
| Location | 2109 Doctors Park Dr, Columbus, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174814644 | NPI | - | NPPES |
| 300065276 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 01087108A (Indiana) | Secondary |
| 2086S0129X | Surgery - Vascular Surgery | 01087108A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Columbus Regional Hospital | Columbus, IN | Hospital |
| Decatur County Memorial Hospital | Greensburg, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johnson Memorial Hospital | 8527972595 | 38 |
| Southern Indiana Surgery Inc | 0840240263 | 3 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved Ferric Citrate (formerly known as Zerenex) for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.
Injections of adult stem cells into damaged heart tissue significantly improved heart function in patients with severe congestive heart failure, according to results of the first prospective randomized trial of the experimental therapy presented today at the American Association for Thoracic Surgery.
Max Planck Florida Institute for Neuroscience Scientific Director, Ryohei Yasuda, has received the National Institute of Health's Pioneer Award, which recognizes scientists who have demonstrated creativity and groundbreaking approaches in biomedical or behavioral science.
A technique pioneered in the Tissue Engineering and Regenerative Medicine Laboratory of Dr. Jeremy Mao, the Edward V. Zegarelli Professor of Dental Medicine at Columbia University Medical Center, can orchestrate stem cells to migrate to a three-dimensional scaffold infused with growth factor, holding the translational potential to yield an anatomically correct tooth in as soon as nine weeks once implanted.
› Verified 5 days ago
| Entity Name | Johnson Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346248986 PECOS PAC ID: 8527972595 Enrollment ID: O20040316000585 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved Ferric Citrate (formerly known as Zerenex) for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.
Injections of adult stem cells into damaged heart tissue significantly improved heart function in patients with severe congestive heart failure, according to results of the first prospective randomized trial of the experimental therapy presented today at the American Association for Thoracic Surgery.
Max Planck Florida Institute for Neuroscience Scientific Director, Ryohei Yasuda, has received the National Institute of Health's Pioneer Award, which recognizes scientists who have demonstrated creativity and groundbreaking approaches in biomedical or behavioral science.
A technique pioneered in the Tissue Engineering and Regenerative Medicine Laboratory of Dr. Jeremy Mao, the Edward V. Zegarelli Professor of Dental Medicine at Columbia University Medical Center, can orchestrate stem cells to migrate to a three-dimensional scaffold infused with growth factor, holding the translational potential to yield an anatomically correct tooth in as soon as nine weeks once implanted.
› Verified 5 days ago
| Entity Name | Decatur County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952300477 PECOS PAC ID: 7315837671 Enrollment ID: O20040318001580 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved Ferric Citrate (formerly known as Zerenex) for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.
Injections of adult stem cells into damaged heart tissue significantly improved heart function in patients with severe congestive heart failure, according to results of the first prospective randomized trial of the experimental therapy presented today at the American Association for Thoracic Surgery.
Max Planck Florida Institute for Neuroscience Scientific Director, Ryohei Yasuda, has received the National Institute of Health's Pioneer Award, which recognizes scientists who have demonstrated creativity and groundbreaking approaches in biomedical or behavioral science.
A technique pioneered in the Tissue Engineering and Regenerative Medicine Laboratory of Dr. Jeremy Mao, the Edward V. Zegarelli Professor of Dental Medicine at Columbia University Medical Center, can orchestrate stem cells to migrate to a three-dimensional scaffold infused with growth factor, holding the translational potential to yield an anatomically correct tooth in as soon as nine weeks once implanted.
› Verified 5 days ago
| Entity Name | Southern Indiana Surgery Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942314554 PECOS PAC ID: 0840240263 Enrollment ID: O20050124000908 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved Ferric Citrate (formerly known as Zerenex) for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.
Injections of adult stem cells into damaged heart tissue significantly improved heart function in patients with severe congestive heart failure, according to results of the first prospective randomized trial of the experimental therapy presented today at the American Association for Thoracic Surgery.
Max Planck Florida Institute for Neuroscience Scientific Director, Ryohei Yasuda, has received the National Institute of Health's Pioneer Award, which recognizes scientists who have demonstrated creativity and groundbreaking approaches in biomedical or behavioral science.
A technique pioneered in the Tissue Engineering and Regenerative Medicine Laboratory of Dr. Jeremy Mao, the Edward V. Zegarelli Professor of Dental Medicine at Columbia University Medical Center, can orchestrate stem cells to migrate to a three-dimensional scaffold infused with growth factor, holding the translational potential to yield an anatomically correct tooth in as soon as nine weeks once implanted.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Chiapaikeo, MD 2109 Doctors Park Dr, Columbus, IN 47203-2224 Ph: (812) 372-2245 | David Chiapaikeo, MD 2109 Doctors Park Dr, Columbus, IN 47203-2224 Ph: (812) 372-2245 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved Ferric Citrate (formerly known as Zerenex) for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.
Injections of adult stem cells into damaged heart tissue significantly improved heart function in patients with severe congestive heart failure, according to results of the first prospective randomized trial of the experimental therapy presented today at the American Association for Thoracic Surgery.
Max Planck Florida Institute for Neuroscience Scientific Director, Ryohei Yasuda, has received the National Institute of Health's Pioneer Award, which recognizes scientists who have demonstrated creativity and groundbreaking approaches in biomedical or behavioral science.
A technique pioneered in the Tissue Engineering and Regenerative Medicine Laboratory of Dr. Jeremy Mao, the Edward V. Zegarelli Professor of Dental Medicine at Columbia University Medical Center, can orchestrate stem cells to migrate to a three-dimensional scaffold infused with growth factor, holding the translational potential to yield an anatomically correct tooth in as soon as nine weeks once implanted.
› Verified 5 days ago
Carlos Vieira, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2326 18th St Ste 230, Columbus, IN 47201 Phone: 812-375-5710 | |
Michael J Dorenbusch, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2325 18th St Ste 220, Columbus, IN 47201 Phone: 812-376-5640 Fax: 812-376-5641 | |
Cory Banaschak, Surgery Medicare: Accepting Medicare Assignments Practice Location: 2325 18th St Ste 220, Columbus, IN 47201 Phone: 812-376-5640 | |
Dr. Justin James Burdick, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2325 18th St Ste 220, Columbus, IN 47201 Phone: 812-376-5640 | |
Dr. Jason Wayne Christie, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2109 Doctors Park Dr, Columbus, IN 47203 Phone: 812-372-2245 | |
Dr. John David Lipson, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 12945 E 100 N, Columbus, IN 47203 Phone: 812-579-9024 |